NovoCure Limited (NVCR)
NASDAQ: NVCR
· Real-Time Price · USD
14.52
0.47 (3.35%)
At close: Oct 03, 2025, 2:28 PM
3.35% (1D)
| Bid | 14.46 |
| Market Cap | 1.62B |
| Revenue (ttm) | 630.16M |
| Net Income (ttm) | -170.95M |
| EPS (ttm) | -1.69 |
| PE Ratio (ttm) | -8.59 |
| Forward PE | -8.32 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 18.17 |
| Volume | 549,130 |
| Avg. Volume (20D) | 1,748,017 |
| Open | 14.17 |
| Previous Close | 14.05 |
| Day's Range | 14.15 - 14.67 |
| 52-Week Range | 10.87 - 34.13 |
| Beta | 0.75 |
| Ex-Dividend Date | n/a |
About NVCR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NVCR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NVCR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNovoCure Limited is scheduled to release its earnings on
Oct 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-24.05%
NocoCure shares are trading lower. The company rep...
Unlock content with
Pro Subscription
4 months ago
-10.83%
NovoCure shares are trading lower after the company announced its PANOVA-3 trial results.
